Clinical Trials Browser

Phase 2/3 × Previously Treated Non-Small Cell Lung Cancer × 90 days × Clear all

NCT03851445 2026-05-18

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

10,000 enrolled

Previously Treated Non-Small Cell Lung Cancer